User:Cailec200/sandbox

TIMP-GLIA is a novel treatment for patients with celiac disease being developed by Cour Phamaceuticals. It is designed to enable patients to develop tolerance to gluten.

TIMP-GLIA is currently being developed and undergoing clinical trials in the US, and is currently in Phase 1. The study is expected to be complete in March 2019.